These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 10217586)

  • 1. IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines.
    Soininen A; Seppälä I; Nieminen T; Eskola J; Käyhty H
    Vaccine; 1999 Apr; 17(15-16):1889-97. PubMed ID: 10217586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
    Anttila M; Eskola J; Ahman H; Käyhty H
    J Infect Dis; 1998 Jun; 177(6):1614-21. PubMed ID: 9607841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT.
    Nurkka A; Ahman H; Yaich M; Eskola J; Käyhty H
    Vaccine; 2001 Oct; 20(1-2):194-201. PubMed ID: 11567764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood.
    Anttila M; Eskola J; Ahman H; Käyhty H
    Vaccine; 1999 Apr; 17(15-16):1970-7. PubMed ID: 10217596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid.
    Korkeila M; Lehtonen H; Ahman H; Leroy O; Eskola J; Käyhty H
    Vaccine; 2000 Jan; 18(13):1218-26. PubMed ID: 10649623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
    Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P
    Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assignment of immunoglobulin G1 and G2 concentrations to pneumococcal capsular polysaccharides 3, 6B, 14, 19F, and 23F in pneumococcal reference serum 89-SF.
    Soininen A; Seppälä I; Wuorimaa T; Käyhty H
    Clin Diagn Lab Immunol; 1998 Jul; 5(4):561-6. PubMed ID: 9665967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.
    Wuorimaa T; Dagan R; Väkeväinen M; Bailleux F; Haikala R; Yaich M; Eskola J; Käyhty H
    J Infect Dis; 2001 Nov; 184(9):1211-5. PubMed ID: 11598848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumococcal conjugate vaccination in toddlers: mucosal antibody response measured as circulating antibody-secreting cells and as salivary antibodies.
    Nieminen T; Käyhty H; Leroy O; Eskola J
    Pediatr Infect Dis J; 1999 Sep; 18(9):764-72. PubMed ID: 10493335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course of antibody response to tetanus toxoid and pneumococcal capsular polysaccharides in patients infected with HIV.
    Talesnik E; Vial PA; Labarca J; Méndez C; Soza X
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):471-7. PubMed ID: 9859960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens.
    Dagan R; Melamed R; Zamir O; Leroy O
    Pediatr Infect Dis J; 1997 Nov; 16(11):1053-9. PubMed ID: 9384339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine.
    Vidarsson G; Sigurdardottir ST; Gudnason T; Kjartansson S; Kristinsson KG; Ingolfsdottir G; Jonsson S; Valdimarsson H; Schiffman G; Schneerson R; Jonsdottir I
    Infect Immun; 1998 Jun; 66(6):2866-70. PubMed ID: 9596761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine.
    Findlow H; Southern J; Mabey L; Balmer P; Heyderman RS; Auckland C; Morris R; Miller E; Borrow R
    Clin Vaccine Immunol; 2006 Apr; 13(4):507-10. PubMed ID: 16603620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assignment of weight-based immunoglobulin G1 (IgG1) and IgG2 units in antipneumococcal reference serum lot 89-S(F) for pneumococcal polysaccharide serotypes 1, 4, 5, 7F, 9V, and 18C.
    Sikkema DJ; Ziembiec NA; Jones TR; Hildreth SW; Madore DV; Quataert SA
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):218-23. PubMed ID: 15643011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G class and subclass antibodies to pneumococcal capsular polysaccharides.
    Chudwin DS; Artrip SG; Schiffman G
    Clin Immunol Immunopathol; 1987 Jul; 44(1):114-21. PubMed ID: 3297436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants.
    Ahman H; Käyhty H; Tamminen P; Vuorela A; Malinoski F; Eskola J
    Pediatr Infect Dis J; 1996 Feb; 15(2):134-9. PubMed ID: 8822286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.
    Dagan R; Muallem M; Melamed R; Leroy O; Yagupsky P
    Pediatr Infect Dis J; 1997 Nov; 16(11):1060-4. PubMed ID: 9384340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of specific immunoglobulin G (IgG) and its subclasses (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population: proposal for response criteria.
    Rodrigo MJ; Miravitlles M; Cruz MJ; de Gracia J; Vendrell M; Pascual C; Morell F
    Clin Diagn Lab Immunol; 1997 Mar; 4(2):168-72. PubMed ID: 9067650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine.
    Weiss PJ; Wallace MR; Oldfield EC; O'Brien J; Janoff EN
    J Infect Dis; 1995 May; 171(5):1217-22. PubMed ID: 7751696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.